Arkolith/Insider Trading/ALMR/Form 4

White Timothy Ogden

PresidentAlamar Biosciences, Inc. (ALMR) · full profile →Form 4 · filed Apr 20, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
18
3 non-derivative · 15 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 20, 2026Grant(A)37K—$0492K
Apr 20, 2026Other(J)455K——0
Apr 20, 2026Other(J)455K——455K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 20, 2026Other(J)9K—$00
Apr 20, 2026Other(J)9K—$09K
Apr 20, 2026Other(J)11K—$00
Apr 20, 2026Other(J)11K—$011K
Apr 20, 2026Other(J)207K—$00
Apr 20, 2026Other(J)207K—$0207K
Apr 20, 2026Other(J)9K—$00
Apr 20, 2026Other(J)9K—$09K
Apr 20, 2026Other(J)6K—$00
Apr 20, 2026Other(J)6K—$06K
Apr 20, 2026Other(J)16K—$00
Apr 20, 2026Other(J)16K—$016K
Apr 20, 2026Other(J)29K—$00
Apr 20, 2026Other(J)29K—$029K
Apr 16, 2026Grant(A)163K—$0163K

Transaction Codes

A
Grant / award
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002126704-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML